351 related articles for article (PubMed ID: 9627714)
1. Analysis and significance of the malignant 'eclipse' during the progression of primary cutaneous human melanomas.
Kerbel RS; Kobayashi H; Graham CH; Lu C
J Investig Dermatol Symp Proc; 1996 Apr; 1(2):183-7. PubMed ID: 9627714
[TBL] [Abstract][Full Text] [Related]
2. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
3. Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine-resistant phenotype.
Kobayashi H; Man S; MacDougall JR; Graham CH; Lu C; Kerbel RS
Am J Pathol; 1994 Apr; 144(4):776-86. PubMed ID: 8160777
[TBL] [Abstract][Full Text] [Related]
4. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
Lu C; Rak JW; Kobayashi H; Kerbel RS
Cancer Res; 1993 Jun; 53(12):2708-11. PubMed ID: 8504408
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.
Lu C; Kerbel RS
J Cell Biol; 1993 Mar; 120(5):1281-8. PubMed ID: 8436594
[TBL] [Abstract][Full Text] [Related]
6. [Examination of different factors influencing the vascularization of human cutaneous melanoma].
Kiss J
Magy Onkol; 2008 Dec; 52(4):385-9. PubMed ID: 19068467
[TBL] [Abstract][Full Text] [Related]
7. Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.
Barnhill RL; Levy MA
Am J Pathol; 1993 Jul; 143(1):99-104. PubMed ID: 7686347
[TBL] [Abstract][Full Text] [Related]
8. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.
Straume O; Akslen LA
Am J Pathol; 2002 Mar; 160(3):1009-19. PubMed ID: 11891198
[TBL] [Abstract][Full Text] [Related]
9. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells.
MacDougall JR; Bani MR; Lin Y; Rak J; Kerbel RS
Cancer Res; 1995 Sep; 55(18):4174-81. PubMed ID: 7664294
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.
Goydos JS; Gorski DH
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5962-7. PubMed ID: 14676121
[TBL] [Abstract][Full Text] [Related]
11. Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8.
Schaider H; Oka M; Bogenrieder T; Nesbit M; Satyamoorthy K; Berking C; Matsushima K; Herlyn M
Int J Cancer; 2003 Jan; 103(3):335-43. PubMed ID: 12471616
[TBL] [Abstract][Full Text] [Related]
12. Tumor progression in the human melanocytic system.
Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma progression.
Gorski DH; Leal AD; Goydos JS
J Am Coll Surg; 2003 Sep; 197(3):408-18. PubMed ID: 12946796
[TBL] [Abstract][Full Text] [Related]
14. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha.
Torisu H; Ono M; Kiryu H; Furue M; Ohmoto Y; Nakayama J; Nishioka Y; Sone S; Kuwano M
Int J Cancer; 2000 Jan; 85(2):182-8. PubMed ID: 10629075
[TBL] [Abstract][Full Text] [Related]
15. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
[TBL] [Abstract][Full Text] [Related]
16. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression.
Lu C; Vickers MF; Kerbel RS
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9215-9. PubMed ID: 1409627
[TBL] [Abstract][Full Text] [Related]
18. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in cutaneous melanoma: pathogenesis and clinical implications.
Srivastava A; Ralhan R; Kaur J
Microsc Res Tech; 2003 Feb; 60(2):208-24. PubMed ID: 12539175
[TBL] [Abstract][Full Text] [Related]
20. Vascular retardation in dormant growth-stunted malignant melanomas.
Piérard-Franchimont C; Henry F; Heymans O; Piérard GE
Int J Mol Med; 1999 Oct; 4(4):403-6. PubMed ID: 10493982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
